欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
TAK-779_229005-80-5_产品详情
229005-80-5
  • names:

    TAK-779

  • CAS号:

    229005-80-5

    MDL Number:
  • MF(分子式): C33H39ClN2O2 MW(分子量): 531.13
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
TAK-779
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000626-10mg 10mg 99.73% ¥ 2497.50 ¥ 2497.50 2-3天
- +
¥ 0.00
YZM000626-5mg 5mg 99.73% ¥ 1339.00 ¥ 1339.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 229005-80-5
Inchi
InchiKey
分子式 Formula C33H39ClN2O2
分子量 Molecular Weight 531.13
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 25 mg/mL(47.07 mM)H2O : 16.66 mg/mL(31.37 mM;Need ultrasonic and warming)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
TAK-779(CAS:229005-80-5)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 TAK-779 是一种有效的,选择性的,非肽类CCR5和CXCR3拮抗剂,对CCR5的Ki值为 1.1 nM,同时可以有效地,选择性地抑制R5 HIV-1,在 MAGI-CCR5 细胞中,EC50和EC90值分别为 1.2 nM 和 5.7 nM
IntroductionTAK79 is a potent and selective nonpeptide antagonist of CCR5andCXCR3, with aKiof 1.1 nM for CCR5, and effectively and selectively inhibitsR5 HIV, withEC50andEC90of 1.2 nM and 5.7 nM, respectively, in MAGICR5 cells.
Application1
Application2
Application3
TAK-779 是一种有效的,选择性的,非肽类CCR5和CXCR3拮抗剂,对CCR5的Ki值为 1.1 nM,同时可以有效地,选择性地抑制R5 HIV-1,在 MAGI-CCR5 细胞中,EC50和EC90值分别为 1.2 nM 和 5.7 nM。TAK-779 is a potent and selective nonpeptide antagonist ofCCR5andCXCR3, with aKiof 1.1 nM for CCR5, and effectively and selectively inhibitsR5 HIV-1, withEC50andEC90of 1.2 nM and 5.7 nM, respectively, in MAGI-CCR5 cells.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Baba M, et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5698-703.
【2】.Takama Y, et al. Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model. Transpl Immunol. 2011 Jul;25(1):49-55.
【3】.Ni J, et al. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function. Br J Pharmacol. 2009 Dec;158(8):2046-56.
【4】.Gao P, et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J Leukoc Biol. 2003 Feb;73(2):273-80.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents